WELLS FARGO & COMPANY/MN - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,996,144
-25.2%
129,591
-15.2%
0.00%0.0%
Q2 2023$4,005,524
+46.3%
152,766
+43.6%
0.00%0.0%
Q1 2023$2,738,323
+77.1%
106,384
+78.9%
0.00%
Q4 2022$1,546,347
-17.4%
59,452
-9.4%
0.00%
-100.0%
Q3 2022$1,872,000
+7.3%
65,600
-7.4%
0.00%0.0%
Q2 2022$1,745,000
-63.6%
70,854
-16.6%
0.00%0.0%
Q1 2022$4,796,000
-9.5%
84,959
-0.6%
0.00%0.0%
Q4 2021$5,299,000
+32.8%
85,488
+35.9%
0.00%0.0%
Q3 2021$3,991,000
+23.1%
62,912
+59.9%
0.00%0.0%
Q2 2021$3,242,000
+145.6%
39,346
+119.2%
0.00%
Q1 2021$1,320,000
-46.2%
17,951
-47.0%
0.00%
-100.0%
Q4 2020$2,454,000
+253.6%
33,841
+132.2%
0.00%
Q3 2020$694,000
-4.0%
14,577
-15.3%
0.00%
Q2 2020$723,000
+303.9%
17,204
+159.6%
0.00%
Q1 2020$179,000
+272.9%
6,627
+429.7%
0.00%
Q4 2019$48,000
+433.3%
1,251
+212.8%
0.00%
Q3 2019$9,0004000.00%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,081,307$79,3139.91%
Finepoint Capital LP 614,231$15,810,3066.04%
M28 Capital Management LP 197,700$5,088,7985.75%
Boxer Capital, LLC 3,421,541$88,0704.33%
Deep Track Capital, LP 3,100,000$79,794,0003.28%
EcoR1 Capital, LLC 3,460,208$89,065,7542.87%
Artal Group S.A. 1,817,349$46,7792.78%
Orbimed Advisors 4,498,900$115,801,6862.27%
Perceptive Advisors 2,079,352$53,522,5201.58%
SPHERA FUNDS MANAGEMENT LTD. 317,625$8,175,6681.37%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders